New trial commencing soon

New trial commencing soon

The Peter MacCallum Cancer Centre will be commencing a phase Ib/II trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in patients with unresectable stage three and four melanoma.

This ANZMTG 01.15 CHARLI Study will be opening to recruitment soon.

For more information please click here or email ANZMTG.